ERIS.NS

Eris Lifesciences Limited [ERIS.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ERIS.NS Stock Summary

Top 10 Correlated Stocks

ERIS.NS


In the News

ERIS.NS Financial details

Company Rating
Buy
Market Cap
114.66B
Income
3.86B
Revenue
18.41B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3.55K
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
32.04
Forward P/E
25.59
PEG
-64.71
P/S
6.97
P/B
5.12
P/C
-
P/FCF
3961.27
Quick Ratio
1.1
Current Ratio
1.93
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
28.41
EPS next Y
32.95
EPS next Q
-
EPS this Y
-5.99%
EPS next Y
15.97%
EPS next 5Y
123.86%
EPS last 5Y
5.85%
Revenue last 5Y
11.43%
Revenue Q/Q
-3.4%
EPS Q/Q
-16.85%
-
-
-
-
SMA20
-2.88%
SMA50
-7.76%
SMA100
-0.94%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
33%
ROC
0.14%
Gross Margin
81%
Oper. Margin
26%
Profit Margin
22%
Payout
-
Shs Outstand
136.03M
Shs Float
33.48M
-
-
-
-
Target Price
-
52W Range
555.0-971.9
52W High
-13.15%
52W Low
+51.95%
RSI
42
Rel Volume
0.25
Avg Volume
235.14K
Volume
59.65K
Perf Week
-0.3%
Perf Month
-2.56%
Perf Quarter
-4.46%
Perf Half Y
1.81%
-
-
-
-
Beta
0.419
-
-
Volatility
2.08%, 20.66%
Prev Close
0.28%
Price
843.35
Change
-0.04%

ERIS.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
70.3377.1387.8497.6122.21
Net income per share
21.1521.6126.1629.8928.1
Operating cash flow per share
16.2219.7627.6427.8421.45
Free cash flow per share
13.458.7325.7518.93-40.42
Cash per share
23.4510.353.8513.046.56
Book value per share
83.6694.49116.1140.45161.49
Tangible book value per share
33.5736.7758.8485.020.61
Share holders equity per share
83.6694.49116.1140.45161.49
Interest debt per share
14.491.040.636.5266.4
Market cap
87.5B50.61B82.15B93.58B77.79B
Enterprise value
89.19B50.06B81.85B93.91B86B
P/E ratio
30.0917.0723.1323.0420.36
Price to sales ratio
9.054.786.897.064.68
POCF ratio
39.2418.6721.8824.7426.67
PFCF ratio
47.342.2323.536.38-14.15
P/B Ratio
7.613.95.214.93.54
PTB ratio
7.613.95.214.93.54
EV to sales
9.224.736.867.085.18
Enterprise value over EBITDA
25.4813.2118.8418.915.7
EV to operating cash flow
39.9918.4621.824.8329.48
EV to free cash flow
48.2141.7723.4136.51-15.65
Earnings yield
0.030.060.040.040.05
Free cash flow yield
0.020.020.040.03-0.07
Debt to equity
0.150.0100.040.4
Debt to assets
0.110.0100.040.24
Net debt to EBITDA
0.48-0.15-0.070.071.5
Current ratio
1.92.912.83.141.73
Interest coverage
13.49148.87215.1102.3916.11
Income quality
0.70.820.950.860.72
Dividend Yield
00.010.010.010.01
Payout ratio
00.160.210.20.26
Sales general and administrative to revenue
0.030.030.040.040.03
Research and developement to revenue
0000.020
Intangibles to total assets
0.460.510.420.330.6
Capex to operating cash flow
-0.17-0.56-0.07-0.32-2.88
Capex to revenue
-0.04-0.14-0.02-0.09-0.51
Capex to depreciation
-1.05-3.01-0.6-1.87-7.19
Stock based compensation to revenue
00000
Graham number
199.51214.36261.39307.33319.56
ROIC
0.210.220.220.190.12
Return on tangible assets
0.340.390.340.270.26
Graham Net
8.075.580.93.08-78.63
Working capital
2.76B3.15B3B4.28B3.21B
Tangible asset value
4.62B5.04B7.99B11.55B82.32M
Net current asset value
1.97B2.24B2.09B2.63B-6.82B
Invested capital
0.150.0100.040.4
Average receivables
1.52B1.92B2.18B2.27B2.61B
Average payables
420.63M920.88M1.01B1.1B1.21B
Average inventory
740.51M760.64M819.71M1.06B1.25B
Days sales outstanding
66.4371.6269.862.2365.17
Days payables outstanding
197.92204.32154.86164.83129.25
Days of inventory on hand
194.45141.88142.56165.02136.15
Receivables turnover
5.495.15.235.875.6
Payables turnover
1.841.792.362.212.82
Inventory turnover
1.882.572.562.212.68
ROE
0.250.230.230.210.17
Capex per share
-2.76-11.03-1.9-8.91-61.88

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
30.7329.1633.8336.8235.53
Net income per share
7.494.816.989.087.55
Operating cash flow per share
4.40.236.016.196.72
Free cash flow per share
4.40.236.016.196.72
Cash per share
5.226.566.5614.140
Book value per share
151.27161.47163.3177.40
Tangible book value per share
00.61020.020
Share holders equity per share
151.27161.47163.3177.40
Interest debt per share
0.2265.111.2862.221.33
Market cap
88.02B77.81B95.04B119.12B123.26B
Enterprise value
88.73B86.01B95.94B125.69B123.26B
P/E ratio
21.629.7325.0524.1329.99
Price to sales ratio
21.0719.6220.6623.825.49
POCF ratio
147.212.49K116.21141.49134.81
PFCF ratio
147.212.49K116.21141.49134.81
P/B Ratio
4.283.544.284.940
PTB ratio
4.283.544.284.940
EV to sales
21.2421.6920.8525.1125.49
Enterprise value over EBITDA
63.6371.7456.1968.0868.59
EV to operating cash flow
148.392.76K117.3149.3134.81
EV to free cash flow
148.392.76K117.3149.3134.81
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.0100.010.010.01
Debt to equity
00.400.340
Debt to assets
00.2400.210
Net debt to EBITDA
0.516.840.523.560
Current ratio
01.7301.930
Interest coverage
36.499.567.428.757.4
Income quality
0.590.050.860.680.89
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.3000
Research and developement to revenue
00.02000
Intangibles to total assets
00.600.560
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00.01000
Graham number
159.67132.19160.09190.380
ROIC
0.050.020.050.040
Return on tangible assets
00.0400.070
Graham Net
5.22-78.616.56-67.650
Working capital
709.59M3.21B892.43M4.64B0
Tangible asset value
082.32M02.72B0
Net current asset value
709.59M-6.82B892.43M-4.86B0
Invested capital
00.400.340
Average receivables
1.48B1.48B1.48B1.77B1.77B
Average payables
582.85M623.85M623.85M752.63M752.63M
Average inventory
542.6M657.18M657.18M695.45M695.45M
Days sales outstanding
067.33063.820
Days payables outstanding
0154.340143.210
Days of inventory on hand
0162.580132.330
Receivables turnover
01.3401.410
Payables turnover
00.5800.630
Inventory turnover
00.5500.680
ROE
0.050.030.040.050
Capex per share
00000

ERIS.NS Frequently Asked Questions

What is Eris Lifesciences Limited stock symbol ?

Eris Lifesciences Limited is a IN stock and trading under the symbol ERIS.NS

What is Eris Lifesciences Limited stock quote today ?

Eris Lifesciences Limited stock price is $843.35 today.

Is Eris Lifesciences Limited stock public?

Yes, Eris Lifesciences Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap